Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for the Primary Prevention of Post-surgical Hypocalcemia
2016-000481-32Phase 2Completed
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of teriparatide in hypocalcemia, sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Change in serum calcium from enrollment to discharge. Started Jun 2021; status: completed.
02
Drugs
teriparatide
03
Conditions
hypocalcemia
Beyond the preview
Go deeper on 2016-000481-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000481-32.